Mannheim, Germany

Ulrich Ebert

USPTO Granted Patents = 21 

 

 

Average Co-Inventor Count = 6.7

ph-index = 6

Forward Citations = 133(Granted Patents)


Location History:

  • Ludwigshafen, DE (2016)
  • Biberach, DE (2015 - 2018)
  • Mannheim, DE (2009 - 2020)

Company Filing History:


Years Active: 2009-2020

Loading Chart...
Loading Chart...
Loading Chart...
21 patents (USPTO):

Title: The Innovations and Contributions of Ulrich Ebert in Neurodegenerative Research

Introduction: Ulrich Ebert, located in Mannheim, Germany, is a prominent inventor whose work has significantly advanced the field of neurodegenerative disease research. With a remarkable portfolio of 21 patents, Ebert has focused on the development of innovative therapies targeting Alzheimer's disease and other amyloidoses.

Latest Patents: Among his latest inventions, Ebert has developed the "Anti-Aβ globulomer 4D10 antibodies" which include various compositions and methods associated with these antibodies. The invention primarily targets Aβ(20-42) globulomer with an enhanced binding affinity compared to Aβ(1-42) globulomer. This breakthrough allows for improved therapeutic and diagnostic applications aimed at combating Alzheimer's disease. His other notable invention includes monoclonal antibodies against the amyloid beta protein, which can be utilized in the prevention, treatment, and diagnosis of Alzheimer’s disease as well as other neurodegenerative disorders.

Career Highlights: Ebert has had a distinguished career, having worked with well-respected entities such as AbbVie Deutschland GmbH & Co. KG and AbbVie Inc. His contributions in these organizations have facilitated significant advancements in the understanding and treatment of diseases related to amyloidosis.

Collaborations: Throughout his career, Ulrich Ebert has collaborated with notable professionals such as Heinz Hillen and Stefan Barghorn. Together, they have combined their expertise to further enhance the efficacy of therapeutic options for patients dealing with complex neurodegenerative conditions.

Conclusion: Ulrich Ebert’s dedication to innovation and his impressive list of patents reflect his commitment to finding solutions for challenging medical issues. His work not only contributes to the scientific community but also offers potential hope for individuals affected by Alzheimer's disease and related ailments. Ebert's ongoing research and developments continue to pave the way for future breakthroughs in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…